Medical Oncologist
CION Cancer Clinics
TACE combined with tablets or immunotherapy: who it is for | CION Cancer Clinics
TACE can sometimes be combined with a targeted tablet or immunotherapy for primary liver cancer that is confined to the liver but too large or widespread to remove. The aim is for each treatment to cover what the other misses. It suits people whose liver is working well, and trials are still showing who gains most. This page explains how the decision is made and who it does not suit. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can TACE be given together with tablets or immunotherapy?
- How do doctors decide whether to add a drug to TACE?
- What does a combined TACE and drug plan look like?
- TACE alone or TACE with a drug: how do they compare?
- What do families often assume about combining treatments?
- Who should not have TACE combined with a drug?
- What this page cannot tell you
- Common questions about TACE with systemic treatment
The short answer
Can TACE be given together with tablets or immunotherapy?
Yes, sometimes. Combining TACE with a targeted tablet or an immunotherapy drip is mainly considered for primary liver cancer (hepatocellular carcinoma, or HCC) that is too large or too spread out within the liver to remove, but has not spread outside it. Doctors call this intermediate disease, or BCLC stage B.
Why anyone combines them
TACE treats the tumours it can reach through their blood supply. It does nothing for small cancer cells that the scan cannot see yet, and blocking the blood supply can itself push the tumour to grow new vessels. A tablet or immunotherapy works through the whole body, so the idea is that each covers a gap the other leaves.
Where the evidence stands
Trials of some combinations have kept the cancer under control for longer than TACE alone. Whether people also live longer is still being studied, and the side effects add up. That is why a combination is a decision made case by case at a tumour board, and is not a standard add-on. If the cancer in your liver started somewhere else, such as the bowel, this page is not about you. Read about cancer that has spread to the liver instead.
TACE is coordinated through accredited partner hospitals. The tablets and immunotherapy are given at CION centres.What the team weighs
How do doctors decide whether to add a drug to TACE?
Three things decide almost every liver cancer plan: the tumour, the liver around it, and the person.
The tumour
How many tumours there are, how big they are, and whether they sit in one part of the liver or both halves. Very large or many tumours respond less completely to TACE alone, which is where a drug is most often discussed.
Liver function
Both treatments put strain on the liver. Your Child-Pugh score, a grade built from blood tests such as bilirubin and albumin, tells the team how much strain your liver can take.
Usually needed
- Well-preserved liver function
- No uncontrolled fluid in the abdomen (ascites)
- No recent confusion from liver disease
Your general fitness
Whether you are up and about most of the day, and how your heart, kidneys and blood pressure are. Some tablets raise blood pressure, and immunotherapy can inflame organs, so other illnesses matter.
Bleeding risk and hepatitis
Swollen veins in the food pipe (varices) are usually checked by endoscopy before some drugs are started. Active hepatitis B is controlled with antiviral tablets first.
Not sure whether this applies to you?
Ask an oncologistHow it runs
What does a combined TACE and drug plan look like?
Tumour board review
Your triple-phase CT or MRI, blood tests and history are reviewed together. The board decides whether TACE alone, a combination, or a drug alone suits you.
Checks before starting
Liver and kidney blood tests, a blood pressure check, and often an endoscopy for varices. Hepatitis B is tested and controlled if present.
TACE and the drug in sequence
Depending on the plan, the drug may start shortly before TACE, soon after it, or once you have recovered. Tablets are usually paused around the procedure. Your team gives you the exact order in writing.
Scans to check response
A repeat scan shows how the tumours responded. The team decides whether to repeat TACE, continue the drug alone, or change course if the cancer is growing.
Side by side
TACE alone or TACE with a drug: how do they compare?
TACE alone
TACE plus a tablet or immunotherapy
Treats the tumours it can reach in the liver
Adds treatment that reaches the whole body
Side effects mostly in the days after each session
Adds the drug's own side effects, which carry on between sessions
Fewer clinic visits between procedures
Regular visits for drips, blood tests and blood pressure checks
Long experience and well understood
Newer, and some combinations are still being tested
Lower total cost
Adds the cost of the drug for as long as it is given
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often assume about combining treatments?
"Two treatments together must be twice as strong."
More treatment is not always better treatment. The liver has to cope with both, and for some people the added strain outweighs the benefit. The right plan is the one your liver can tolerate.
"If TACE is working, the tablet is unnecessary."
Sometimes that is true, and TACE alone is the plan. In other cases the drug is there to deal with what the scan cannot show. Ask your team which situation you are in.
"Starting a drug means TACE has failed."
Not in a combination plan. The drug is part of the plan from the start. A switch to a drug alone after TACE stops working is a different situation, explained on the page about when TACE stops working.
"Immunotherapy is only for people at the very end."
Immunotherapy is now used at several stages of liver cancer, including alongside TACE in some plans. It is a treatment choice, and does not mean options have run out.
Who this does not suit
Who should not have TACE combined with a drug?
A combination is not for everyone with intermediate liver cancer. People with weak liver function, a high bilirubin, fluid in the abdomen that is hard to control, or recent confusion from liver disease are usually not offered it, because the liver may not cope with the strain of both treatments.
Situations that usually rule out a drug
Immunotherapy is generally avoided after a liver transplant and in some people with active autoimmune disease. Some tablets are avoided with uncontrolled blood pressure, recent bleeding, or untreated large varices. Bevacizumab, a drug that blocks blood vessel growth, carries its own bleeding risk.
Situations where TACE itself is not right
If the cancer has spread outside the liver, or the main portal vein is blocked by tumour, TACE is often not the right treatment at all. Then a drug alone, such as atezolizumab plus bevacizumab, is usually considered. How these drugs work is explained on the immunotherapy for liver cancer page.
Being straight with you
What this page cannot tell you
It cannot tell you whether a combination is right for you. That depends on your scans, your blood results and your liver, and it is answered by a tumour board that has seen all three. It also cannot tell you how long treatment will work, because no page can give an individual outlook.
The availability question
Not every combination studied abroad is approved in India for use with TACE, and the drugs are costly. Ask your oncologist which drug is being suggested, whether it is approved for this use in India, and how it would be paid for.
If you have been offered TACE and want a second opinion on whether a drug should be added, bring your scan reports and discs to a CION oncologist.Questions we are asked
Common questions about TACE with systemic treatment
Which drugs are combined with TACE?
Targeted tablets such as lenvatinib and sorafenib, and immunotherapy drips such as durvalumab or pembrolizumab, sometimes with bevacizumab, have been studied with TACE. Which one is suggested depends on your liver, your other illnesses and what is approved and available in India at the time.
Does adding a drug make TACE more painful?
The procedure itself feels the same. Pain, fever and nausea in the days after TACE come from the embolisation, and not from the drug. The drug adds its own effects, such as tiredness, high blood pressure, sore hands and feet, or diarrhoea, which your team will watch for at each visit.
Will I take the tablet on the day of TACE?
Usually not. Tablets are often paused for a short time before and after the procedure so the liver can recover. Never stop or restart a cancer tablet on your own. Your oncologist will give you written dates for when to pause and when to restart.
Can I have this if I have hepatitis B?
Often yes, once the virus is controlled. Your doctor will check your viral load and start antiviral tablets if needed, because both TACE and some cancer drugs can wake the virus up. Hepatitis B is controlled rather than removed, so these tablets usually continue long term.
Is this the same as immunotherapy with Y-90?
The idea is similar but the procedure differs. Y-90 delivers radiation through the liver's blood vessels instead of chemotherapy. Both are being combined with immunotherapy in studies. The TACE vs TARE page explains how the procedure is chosen.
How will I know if the combination is working?
By repeat scans, usually a contrast CT or MRI, and sometimes by the AFP blood test if yours was raised at the start. The team looks for tumours that no longer light up with contrast. One scan rarely settles it, so decisions are made on the trend.
Does insurance cover the drug as well as TACE?
It varies. Many policies treat a procedure and an outpatient drug differently, and government schemes change their rules. Ask for a written, itemised estimate and check cover for each part separately. The CION team can help with the paperwork.
Can I get a second opinion before deciding?
Yes, and it is sensible for a decision like this. Bring your scan discs, reports, blood tests and any discharge summaries. A CION oncologist can review them with the tumour board and explain whether a combination, TACE alone or a drug alone fits your situation.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Embolization Therapy for Liver Cancer
- American Cancer Society — Immunotherapy for Liver Cancer
- American Cancer Society — Targeted Drug Therapy for Liver Cancer
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
BCLC Stage B: IntermediateThe stage where this combination is usually discussedImmunotherapy Combined With TACE or Y-90The immunotherapy side of the combination in more detailWhen TACE Stops WorkingWhat happens if the tumours keep growing after TACETACE for Liver Cancer: How the Procedure WorksThe procedure itself, step by step
Talk to us
Should a drug be added to your TACE?
Share your scans and blood reports, and a CION oncologist will explain whether a combination, TACE alone or a drug alone fits your liver. One helpline serves every CION centre.